Cancer is on the rise worldwide: according to the World Health Organization, there will be over 35 million new Read More
Culmination Bio and BillionToOne partner to validate cancer diagnostics
Culmination Bio is a company on a mission to accelerate the R&D timeline for pharmaceutical and biotech companies, which it Read More
Drug development is a lengthy and costly process, taking over ten years and costing over $1 billion. That’s Read More